D-penicillamine treatment for chronic sensory ataxic neuropathy associated with Sjögren's syndrome.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 9818879.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Beneficial treatment has not been established for chronic sensory ataxic neuropathy associated with Sjögren's syndrome (CSAN-SS). We describe two patients with CSAN-SS who clinically improved in response to D-penicillamine treatment. Their neuropathic symptoms were lessened after D-penicillamine, and the results of electrophysiologic studies support the clinical improvement. D-Penicillamine can be considered a potentially beneficial agent in the treatment of CSAN-SS.
Medical subject headings
- Antirheumatic Agents
- Ataxia
- Neural Conduction
- Penicillamine
- Sjogren's Syndrome